Covered recipient · General Payments record
ABDUL RAZACK
General Payments · PY2019–2025
$5,730.38
- Reported across 227 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,388.06 | 28 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $398.45 | 11 |
| Madrigal Pharmaceuticals | $289.10 | 4 |
| Ardelyx, Inc. | $248.45 | 4 |
| Novo Nordisk AS | $149.20 | 3 |
| Janssen Biotech, Inc. | $139.78 | 2 |
| Gilead Sciences, Inc. | $93.58 | 1 |
| Ipsen Biopharmaceuticals, Inc | $33.15 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $21.08 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $15.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.60 | 07/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795936 | CMS |
| ABBVIE INC. | $13.72 | 07/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795942 | CMS |
| ABBVIE INC. | $34.09 | 08/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795948 | CMS |
| ABBVIE INC. | $112.00 | 09/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795954 | CMS |
| ABBVIE INC. | $26.07 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795959 | CMS |
| ABBVIE INC. | $27.74 | 10/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795966 | CMS |
| ABBVIE INC. | $23.78 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795971 | CMS |
| ABBVIE INC. | $89.81 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795976 | CMS |
| ABBVIE INC. | $20.35 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795984 | CMS |
| ABBVIE INC. | $7.74 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795990 | CMS |
| ABBVIE INC. | $16.55 | 12/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1203795995 | CMS |
| Aimmune Therapeutics, Inc. | $21.08 | 10/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249650539 | CMS |
| Ardelyx, Inc. | $83.96 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247878081 | CMS |
| Ardelyx, Inc. | $21.61 | 08/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247878083 | CMS |
| Ardelyx, Inc. | $18.68 | 12/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247878085 | CMS |
| Ardelyx, Inc. | $124.20 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247878087 | CMS |
| Boston Scientific Corporation | $15.27 | 06/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181564769 | CMS |
| Gilead Sciences, Inc. | $93.58 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234404021 | CMS |
| Ipsen Biopharmaceuticals, Inc | $33.15 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208833373 | CMS |
| Janssen Biotech, Inc. | $125.00 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174355882 | CMS |
| Janssen Biotech, Inc. | $14.78 | 11/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174355969 | CMS |
| Madrigal Pharmaceuticals | $116.95 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248302330 | CMS |
| Madrigal Pharmaceuticals | $141.36 | 09/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248302332 | CMS |
| Madrigal Pharmaceuticals | $16.38 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248302334 | CMS |
| Madrigal Pharmaceuticals | $14.41 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1248302336 | CMS |
| Novo Nordisk Inc | $15.07 | 09/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192980949 | CMS |
| Novo Nordisk Inc | $14.07 | 11/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192978759 | CMS |
| Novo Nordisk Inc | $120.06 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1192977595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.